(Q39452477)

12 September 2017

Humanized anti-CD4 monoclonal antibody therapy of autoimmune and inflammatory disease (English)

1 reference

12 September 2017

0 references

1 reference

1 reference

11

H Waldmann

1 reference

12 September 2017

10

G Hale

1 reference

12 September 2017

J D Isaacs

1

1 reference

12 September 2017

N Burrows

2

1 reference

12 September 2017

M Wing

3

1 reference

12 September 2017

M T Keogan

4

1 reference

12 September 2017

P R Rebello

5

1 reference

12 September 2017

R A Watts

6

1 reference

12 September 2017

R J Pye

7

1 reference

12 September 2017

P Norris

8

1 reference

12 September 2017

B L Hazelman

9

1 reference

12 September 2017

1 November 1997

1 reference

Clinical and Experimental Immunology

12 September 2017

1 reference

12 September 2017

110

1 reference

12 September 2017

2

1 reference

12 September 2017

158-166

1 reference

Does exposure to immunosuppressive therapy increase the 10 year malignancy and mortality risks in rheumatoid arthritis? A matched cohort study.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265492

Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis.

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265492

CAMPATH-1H in rheumatoid arthritis--an intravenous dose-ranging study

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265492

The generation of a humanized, non-mitogenic CD3 monoclonal antibody which retains in vitro immunosuppressive properties

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265492

Phase 1 clinical trial of chimeric monoclonal anti-CD4 antibody in multiple sclerosis

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265492

Use of a chimeric monoclonal anti-CD4 antibody in patients with refractory rheumatoid arthritis

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265492

"Infectious" transplantation tolerance.

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265492

Tolerance, danger, and the extended family

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265492

Double-blind, placebo-controlled multicenter trial using chimeric monoclonal anti-CD4 antibody, cM-T412, in rheumatoid arthritis patients receiving concomitant methotrexate

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265492

Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis.

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265492

Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies.

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265492

Tolerance to rat monoclonal antibodies. Implications for serotherapy

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265492

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265492

Human monoclonal IgG isotypes differ in complement activating function at the level of C4 as well as C1q.

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265492

Reshaping human antibodies for therapy

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265492

Importance of antigen specificity for complement-mediated lysis by monoclonal antibodies.

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265492

Induction of tolerance by monoclonal antibody therapy

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265492

Induction of classical transplantation tolerance in the adult

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265492

Anti-CD4 antibody treatment of patients with rheumatoid arthritis: I. Effect on clinical course and circulating T cells

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265492

A matched set of rat/mouse chimeric antibodies. Identification and biological properties of rat H chain constant regions mu, gamma 1, gamma 2a, gamma 2b, gamma 2c, epsilon, and alpha

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265492

In vivo cell activation following OKT3 administration. Systemic cytokine release and modulation by corticosteroids

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265492

Treatment of rheumatoid arthritis with monoclonal CD4 antibody M-T151. Clinical results and immunopharmacologic effects in an open study, including repeated administration

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265492

Treatment of rheumatoid arthritis with an anti-CD4 monoclonal antibody

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265492

Reshaping a therapeutic CD4 antibody

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265492

Immunological effects of high dose administration of anti-CD4 antibody in rheumatoid arthritis patients.

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265492

Therapeutic use of monoclonal anti-CD4 antibody in rheumatoid arthritis

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265492

Therapy with monoclonal antibodies. An in vivo model for the assessment of therapeutic potential

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265492

Reprogramming the immune system for peripheral tolerance with CD4 and CD8 monoclonal antibodies

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265492

Severe Psoriasis – Oral Therapy with a New Retinoid

30 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265492

Ex-vivo whole blood cultures for predicting cytokine-release syndrome: dependence on target antigen and antibody isotype

30 August 2018

1 reference

12 December 2020

Complement activation by immunoglobulin does not depend solely on C1q binding

1 reference

12 December 2020

T-cell subpopulations in the blood and skin of patients with psoriasis

1 reference

12 December 2020

Induction of immune tolerance by administration of monoclonal antibody to L3T4

1 reference

12 December 2020

Administration of F(ab')2 fragments of monoclonal antibody to L3T4 inhibits humoral immunity in mice without depleting L3T4+ cells

1 reference

12 December 2020

A simple method for measuring patient anti-globulin responses against isotypic or idiotypic determinants

1 reference

12 December 2020

Monoclonal-Antibody Therapy in Systemic Vasculitis

1 reference

12 December 2020

Treatment of severe systemic lupus erythematosus with anti-CD4 monoclonal antibody

1 reference

12 December 2020

Humanised monoclonal antibody therapy for rheumatoid arthritis

1 reference

12 December 2020

Anti-CD4 monoclonal antibody therapy in severe psoriasis

1 reference

12 December 2020

Long-term remission of intractable systemic vasculitis with monoclonal antibody therapy

1 reference

12 December 2020

Chimeric CD4 monoclonal antibody cM-T412 as a therapeutic approach to rheumatoid arthritis

1 reference

12 December 2020

Treatment of multiple sclerosis with anti-CD4 monoclonal antibody. A preliminary report on B-F5 in 21 patients

1 reference

12 December 2020

Treatment of refractory rheumatoid arthritis with a chimeric anti-CD4 monoclonal antibody. Long-term followup of CD4+ T cell counts

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled study of CD4 monoclonal antibody therapy in early rheumatoid arthritis

1 reference

12 December 2020

Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis

1 reference

12 December 2020

Rheumatoid arthritis: a disease of T-lymphocyte/macrophage immunoregulation

1 reference

12 December 2020

Helplessness as a strategy for avoiding antiglobulin responses to therapeutic monoclonal antibodies

1 reference

12 December 2020

A therapeutic human IgG4 monoclonal antibody that depletes target cells in humans

1 reference

12 December 2020

Treatment of refractory Wegener's granulomatosis with humanized monoclonal antibodies

1 reference

12 December 2020

10.1111/J.1365-2249.1997.TB08312.X

Identifiers

DOI

1 reference

12 September 2017

0 references

1 reference